Cancer Immunotherapy: Decoding the Cancer Immunity Interactome
Mar 20–24, 2022 | Fairmont Chateau Whistler, Whistler, BC, Canada
Scientific Organizers:
Livestream
In Person
On Demand
Mar 20–24, 2022 | Fairmont Chateau Whistler, Whistler, BC, Canada
Scientific Organizers:
Available Formats:
Livestream
In Person
On Demand
Supported by the Directors' Fund
Important Deadlines
Early Registration Deadline:
Scholarship Deadline:
Global Health Award Deadline:
Short Talk Abstract Deadline:
Poster Abstract Deadline:
Meeting Summary
# Cancer
# Drug Discovery, Bioengineering and Digital
# Immunology
This meeting will proceed as planned. As the omicron surge wanes, we expect it will be safe to convene in-person by this time and will be implementing special COVID-19 safety measures to protect the health and safety of all attendees. It is critically important to both the science, and the scientific community, that we do so, to ensure scientific exchange, connection and innovation that have been stifled by the pandemic. The Science Must Go On.
Although there has been rapid advancement in the understanding of cancer immunity, application of this evolving body of knowledge is impeded by divisions between disciplines and the challenges inherent in remaining abreast of a rapidly developing field. Widening knowledge gaps span the interface between clinical and basic data, as well as between scientists who are focused on disparate immune components of the tumor microenvironment and between systems biology, bioinformatics data and their practical application. In bringing together translational physicians, basic immunologists and cutting-edge systems biologists, this conference will foster interdisciplinary cooperation such that cutting-edge discoveries made in the bioinformatics field will help drive translation and lab-based investigation. Additionally, it will provide a showcase for novel imaging and profiling technologies, fostering their widespread adoption by the cancer immunity field as a whole. Finally, it will highlight recent advances in our understanding of epigenetic control of T cell function. A goal of the conference is to bring together these different groups of scientists and to accelerate the application of new technologies and systems biology approaches to their own research efforts. A well-organized cancer immunity conference focused on bringing together translational and basic investigation, along with cutting edge systems biology and technology approaches represents a novel construct previously not fulfilled by other, isolated silo-like meetings. The disciplines gathered for this conference would not normally co-attend meetings. This program is aimed at addressing these widening knowledge gaps which are being promulgated by a rapidly evolving field.
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS OUR MEETING EXHIBITOR(S):
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates